Department of Cardiology at AIIMS Jammu has initiated advanced cardiac procedures in its newly established Cath Lab, marking ...
Almost three weeks after undergoing heart surgery at NYU Langone in Mineola, Larry Burke, 74, an avid Santa Claus enthusiast, ...
MIT-alumni-founded Thermedical advances novel deep-tissue ablation technology to address critical unmet needs in severe ventricular tachycardia ...
Shorter, nanosecond pulses for treating atrial fibrillation differentiate the company’s approach from existing pulsed field ...
HRS/ACC statement guides expanded access for intracardiac ablation procedures in ambulatory surgical centers for appropriate patients.
Johnson & Johnson MedTech today announced its sponsorship of a new PFA data collection platform from the Heart Rhythm Society ...
As heart disease remains one of the leading causes of death worldwide, timely and expert cardiovascular care is essential for ...
About LockeT Catheter Precision’s LockeT is a suture retention device intended to assist in wound closure after percutaneous venous punctures. LockeT is a Class 1 device registered with the FDA and ...
Abbott (NYSE: ABT) today announced it has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its Amplatzer Piccolo™ Delivery System, which is used with the company's Amplatzer ...
Zacks Investment Research on MSN
PLSE wins FDA IDE approval to launch nPulse AF ablation study trial
Pulse Biosciences PLSE recently announced that the FDA has granted Investigational Device Exemption (“IDE”) approval to ...
The global, multibillion-dollar transcatheter heart valves market will grow at an 8.4% CAGR over the rest of the 2020s, ...
Rising prevalence of valvular heart diseases, expanding elderly population, and growing preference for minimally invasive cardiac procedures are driving the transcatheter heart valve replacement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results